Skin Cancer — Dendritic Cells Therapy LANEX-DC: treatment in the Best Hospitals of Germany
Treatment prices are regulated by national law of the corresponding countries, but can also include additional hospital coefficients. In order to receive the individual cost calculation, please send us the request and medical records.
Department of Oncology and Dendritic Cell Therapy
The Department of Oncology and Dendritic Cell Therapy specializes in the treatment of various types of cancer. The key focus of the work of the department's doctors is advanced LANEX-DC® dendritic cell immunotherapy. Today, the medical facility is one of the world's leading providers of dendritic cell therapy. The department most often admits patients with skin, breast, prostate, pancreatic, kidney, colon, ovarian, etc. cancers. Prior to starting treatment, a patient undergoes comprehensive diagnostics, based on the results of which doctors determine the advisability of cell therapy. Dendritic cell immunotherapy is indicated for patients with advanced cancer who are not responding to standard treatment with chemotherapy, radiation therapy, and other classical methods. Treatment is carried out on an outpatient basis. More than 2,500 LANEX-DC® immunotherapy procedures have been successfully performed in the department, which contributes to the high credibility of the medical facility in this area. The department regularly admits many patients from abroad who want to undergo innovative treatment that is not available in their native country.
Dendritic cell therapy for skin cancer involves modifying the patient's dendritic cells to target and destroy cancer cells. These cells are then reintroduced into the body, enhancing the immune system's ability to fight the tumor effectively.
Benefits include a personalized treatment approach, fewer side effects compared to traditional therapies, and the potential for long-term remission. This therapy is particularly effective for patients with advanced or metastatic skin cancer.
The process, from cell extraction to reintroduction, typically takes a few weeks. Patients may require multiple treatment cycles, depending on their individual response and the progression of the disease.
Yes, dendritic cell therapy can be used in combination with surgery, radiation therapy, and other immunotherapies. Combining treatments can enhance overall effectiveness and improve patient outcomes.
Patients can expect a series of outpatient procedures, including blood draws and injections. Side effects are usually mild, possible symptoms include fever and fatigue. Continuous monitoring ensures the therapy is progressing safely and effectively.
